Ogawa Eiichi 小川栄一

… Alternative Names

Eiichi Ogawa 小川栄一

Less

Researcher Number	70621283
Other IDs
Affiliation (Current)	2025: 九州大学, 大学病院, 講師
Affiliation (based on the past Project Information) *help	2020 – 2022: 九州大学, 医学研究院, 助教 2016 – 2018: 九州大学, 医学研究院, 助教 2014 – 2015: 九州大学, 医学(系)研究科(研究院), 助教
Review Section/Research Field	Principal Investigator Infectious disease medicine / Basic Section 54030:Infectious disease medicine-related Except Principal Investigator Basic Section 54030:Infectious disease medicine-related / Infectious disease medicine
Keywords	Principal Investigator C型肝炎ウイルス / Ｃ型肝炎ウイルス / 肝脂肪化 / GWAS / 非アルコール性脂肪性肝炎 / 脂肪性肝炎 / 肝細胞癌 / 感染症 / ウイルス / 血清補体価 … More / 慢性腎臓病 / C型慢性肝炎 / プロテアーゼ阻害剤 / インターフェロン / Real-time PCR法 / DAA / リアルタイムPCR法 … More Except Principal Investigator C型慢性肝炎 / 高齢者 / 肝癌 / 経口抗HCV薬 / 肝細胞癌 / ウイルス血症消失 / インターロイキン28B / TA repeat / ウイルス自然排除 / インターロイキン28B遺伝子 / 自然排除 / 持続感染 / C型肝炎ウイルス / 一般住民 / African Americans / Japanese population / Spontaneous clearance / Interleukin 28B / Hepatitis C virus Less

Evaluation for the liver fibrosis and hepatocellular carcinoma incidence after HCV elimination in patients with chronic hepatitis CPrincipal Investigator
- Principal Investigator
  
  Ogawa Eiichi
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54030:Infectious disease medicine-related
- Research Institution
  Kyushu University
Hepatocellular carcinoma following hepatitis C virus eradication by direct-acting antivirals
- Principal Investigator
  
  古庄憲浩
- Project Period (FY)
  2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54030:Infectious disease medicine-related
- Research Institution
  Kyushu University
Kidney-associated molecular and immunological analysis in treatment with direct-acting antivirals for hepatitis C virus infectionPrincipal Investigator
- Principal Investigator
  
  OGAWA EIICHI
- Project Period (FY)
  2017 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Infectious disease medicine
- Research Institution
  Kyushu University
Hepatitis C virus kinetics and optimized therapy in DAA treatmentPrincipal Investigator
- Principal Investigator
  
  Eiichi Ogawa
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Infectious disease medicine
- Research Institution
  Kyushu University
Spontaneous clearance of Hepatitis C virus infection
- Principal Investigator
  
  Norihiro Furusyo
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Infectious disease medicine
- Research Institution
  Kyushu University

All 2023 2022 2021 2020 2018 2017 2016 2015 2014 Other

All Journal Article Presentation

[Journal Article] Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct-acting antivirals2022
- Author(s)
  Eiichi Ogawa
- Journal Title
  
  Journal of Gastroenterology and Hepatology
  
  Volume: 37 Issue: 1 Pages: 190-199
- DOI
  10.1111/jgh.15659
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08820
[Journal Article] Long-term hepatic function of patients with compensated cirrhosis following successful direct-acting antiviral treatment for hepatitis C virus infection2022
- Author(s)
  Eiichi Ogawa
- Journal Title
  
  Journal of Gastroenterology and Hepatology
  
  Volume: 37 Issue: 2 Pages: 371-377
- DOI
  10.1111/jgh.15703
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08820
[Journal Article] Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C2020
- Author(s)
  Eiichi Ogawa
- Journal Title
  
  Cancers
  
  Volume: 12 Issue: 9 Pages: 2602-2602
- DOI
  10.3390/cancers12092602
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08820
[Journal Article] Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination2020
- Author(s)
  Eiichi Ogawa
- Journal Title
  
  Alimentary Pharmacology and Therapeutics
  
  Volume: 52 Issue: 5 Pages: 866-876
- DOI
  10.1111/apt.15976
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08820
[Journal Article] Elbasvir plus grazoprevir for patients with chronic hepatitis C genotype 1: A multicenter, real-world cohort study focusing on chronic kidney disease2018
- Author(s)
  Ogawa E, Furusyo N, et al
- Journal Title
  
  Antiviral Research
  
  Volume: 159 Pages: 143-152
- DOI
  10.1016/j.antiviral.2018.10.003
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K16225
[Journal Article] Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapy2017
- Author(s)
  Ogawa E, Furusyo N, Murata M, Shimizu M, Toyoda K, Hotta T, Uchiumi T, Hayashi J
- Journal Title
  
  Antiviral Therapy
  
  Volume: 22 Issue: 1 Pages: 61-70
- DOI
  10.3851/imp3085
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15K19586
[Journal Article] Impact of HCV kinetics on treatment outcome differs by the type of real-time HCV assay in NS3/4A protease inhibitor-based triple therapy2016
- Author(s)
  Ogawa E, Furusyo N, Murata M, Hayashi T, Shimizu M, Mukae H, Toyoda K, Hotta T, Uchiumi T, Hayashi J
- Journal Title
  
  Antiviral Research
  
  Volume: 126 Pages: 35-42
- DOI
  10.1016/j.antiviral.2015.12.001
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15K19586
[Journal Article] Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study.2016
- Author(s)
  Ikezaki H, Furusyo N, Hiramine S, Ura K, Mitsumoto-Kaseida F, Takayama K, Shimizu M, Toyoda K, Ogawa E, Kainuma M, Murata M, Hayashi J.
- Journal Title
  
  Archives of Virology
  
  Volume: 161 (3) Issue: 3 Pages: 641-648
- DOI
  10.1007/s00705-015-2703-9
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461506
[Journal Article] Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological response.2014
- Author(s)
  Furusyo N, Ogawa E, Murata M, Toyoda K, Ohnishi H, Eiraku K, Shimizu M, Harada Y, Mitsumoto F, Takayama K, Kainuma M, Okada K, Hayashi J.
- Journal Title
  
  Journal of Antimicrobilal Chemotherapy
  
  Volume: 69(2) Issue: 2 Pages: 483-490
- DOI
  10.1093/jac/dkt371
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26461506
[Journal Article] Hepatitis B Virus-related Immune Reconstitution Inflammatory Syndrome in Two Patients Coinfected with Human Immunodeficiency Virus Diagnosed with a Liver Biopsy2014
- Author(s)
  Mitsumoto F, Murata M, Kato Y, Ura K, Takayama K, Hiramine S, Ikezaki H, Shimizu M, Toyoda K, Ogawa E, Aishima S, Furusyo N, Hayashi J.
- Journal Title
  
  Intern. Med.
  
  Volume: 53 Issue: 18 Pages: 2165-2170
- DOI
  10.2169/internalmedicine.53.2503
- NAID
  130004687659
- ISSN
  0918-2918, 1349-7235
- Language
  English
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26461506
[Journal Article] Nocturnal Difference in the Ultra Low Frequency Band of Heart Rate Variability in Patients Stratified by Kampo Medicine Prescription2014
- Author(s)
  Kainuma M, Furusyo N, Ando S, Mukae H, Ogawa E, Toyoda K, Murata M, Hayashi J.
- Journal Title
  
  Circ J
  
  Volume: 78 Issue: 8 Pages: 1924-1927
- DOI
  10.1253/circj.CJ-14-0362
- NAID
  130004926991
- ISSN
  1346-9843, 1347-4820
- Language
  English
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26461506
[Journal Article] Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis.2014
- Author(s)
  Ogawa E, Furusyo N, Nakamuta M, Kajiwara E, Nomura H, Dohmen K, Takahashi K, Satoh T, Azuma K, Kawano A, Tanabe Y, Kotoh K, Shimoda S, Akahoshi T, Maehara Y, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group.
- Journal Title
  
  Journal of Gastroenterology and Hepatology
  
  Volume: 29(9) Issue: 9 Pages: 1728-1735
- DOI
  10.1111/jgh.12619
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26461506
[Journal Article] Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection.2014
- Author(s)
  Ogawa E, Furusyo N, Kajiwara E, Nomura H, Dohmen K, Takahashi K, Nakamuta M, Satoh T, Azuma K, Kawano A, Tanabe Y, Kotoh K, Shimoda S, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group.
- Journal Title
  
  Antiviral Research
  
  Volume: 104 Pages: 102-109
- DOI
  10.1016/j.antiviral.2014.01.004
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26461506
[Presentation] Predictors of advanced liver disease for chronic hepatitis C patients after sustained virological response following DAA treatment2023
- Author(s)
  Eiichi Ogawa
- Organizer
  APASL 2023 (アジア太平洋肝臓学会議)
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08820
[Presentation] 代謝関連因子およびPNPLA3遺伝子多型を含めたSVR後肝癌発症に関する検討2022
- Author(s)
  小川栄一
- Organizer
  第26回日本肝臓学会大会
- Data Source
  KAKENHI-PROJECT-20K08820
[Presentation] 慢性腎臓病症例におけるHCV排除後の腎機能・肝発癌・長期予後の実態2022
- Author(s)
  小川栄一
- Organizer
  第58回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-20K08820
[Presentation] Nationwide population-level real-world evidence of long-term mortality, liver and non-liver benefits of DAA therapy in patients with chronic hepatitis treated with direct-acting antivirals2022
- Author(s)
  Eiichi Ogawa
- Organizer
  AASLD 2022 (米国肝臓学会議)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08820
[Presentation] Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by DAAs2021
- Author(s)
  Eiichi Ogawa
- Organizer
  The Liver Meeting (AASLD) 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08820
[Presentation] DAA治療後SVR症例の肝発癌リスク層別化の検討2021
- Author(s)
  小川栄一
- Organizer
  第25回日本肝臓学会大会 (JDDW 2021)
- Data Source
  KAKENHI-PROJECT-20K08820
[Presentation] DAA治療によるSVR長期経過後の肝機能の推移2021
- Author(s)
  小川栄一
- Organizer
  第57回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-20K08820
[Presentation] 肝脂肪化からみたPost SVR肝癌に関する検討～FAST scoreおよびPNPLA3遺伝子との関連について2021
- Author(s)
  小川栄一
- Organizer
  第57回日本肝臓学会総会（パネルディスカッション）
- Data Source
  KAKENHI-PROJECT-20K08820
[Presentation] DAA治療別のSVR後肝発癌に関する検討～Sofosbuvir-baseとSofosbuvir-freeの比較2021
- Author(s)
  小川栄一
- Organizer
  第107回日本消化器病学会総会（シンポジウム）
- Data Source
  KAKENHI-PROJECT-20K08820
[Presentation] DAA治療によるHCV排除後の高齢者肝癌の実態2020
- Author(s)
  小川栄一
- Organizer
  第24回日本肝臓学会大会 (JDDW 2020)
- Data Source
  KAKENHI-PROJECT-20K08820
[Presentation] Development of hepatocellular carcinoma by the older generations of patients after HCV cure by all-oral DAA therapy2020
- Author(s)
  Eiichi Ogawa
- Organizer
  The Liver Meeting (AASLD) 2020
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08820
[Presentation] C型慢性肝炎に対するDAA治療によるSVR後肝発癌の検討2018
- Author(s)
  小川栄一、古庄憲浩、中牟田誠
- Organizer
  第26回日本肝臓学会大会（JDDW 2018）
- Data Source
  KAKENHI-PROJECT-18K08433
[Presentation] 高齢者および肝線維化進展例に対する C型慢性肝炎DAA治療の実臨床成績2017
- Author(s)
  小川　栄一
- Organizer
  第91回日本感染症学会総会
- Data Source
  KAKENHI-PROJECT-17K16225
[Presentation] 慢性腎臓病（CKD ステージ 3）合併C型慢性肝炎に対するソホスブビル治療効果と安全性2017
- Author(s)
  小川　栄一、その他
- Organizer
  第53回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-17K16225
[Presentation] C 型慢性肝炎に対するソホスブビル治療の成果と課題2017
- Author(s)
  小川　栄一
- Organizer
  第53回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-17K16225
[Presentation] C型慢性肝炎に対するDAA治療におけるウイルス動態の意義2016
- Author(s)
  小川栄一
- Organizer
  第64回日本化学療法学会西日本支部総会
- Place of Presentation
  沖縄
- Year and Date
  2016-11-25
- Data Source
  KAKENHI-PROJECT-15K19586
[Presentation] C型慢性肝炎のDAA治療におけるウイルス動態の意義-TaqMan法とAccuGene法の比較2016
- Author(s)
  小川栄一
- Organizer
  第52回日本肝臓学会総会
- Place of Presentation
  千葉
- Year and Date
  2016-05-19
- Data Source
  KAKENHI-PROJECT-15K19586
[Presentation] Accugene PCR法によるC型慢性肝炎に対するDAA3剤療法のウイルス動態と効果予測の検討2015
- Author(s)
  小川　栄一
- Organizer
  第11回日本病院総合診療医学会総会
- Place of Presentation
  奈良
- Year and Date
  2015-09-04
- Data Source
  KAKENHI-PROJECT-15K19586
[Presentation] C型肝炎ウイルス自然排除とインターロイキン28B遺伝子プロモーター領域のTA repeatの関連の検討
- Author(s)
  平峯　智、古庄憲浩、光本富士子、髙山耕治、浦　和也、志水元洋、豊田一弘、小川栄一、貝沼茂三郎、村田昌之、溝上雅史、林　純
- Organizer
  第88回日本感染症学会学術講演会
- Place of Presentation
  福岡市
- Year and Date
  2014-06-18 – 2014-06-20
- Data Source
  KAKENHI-PROJECT-26461506

1. Norihiro Furusyo (10346786)

# of Collaborated Projects: 4 results

# of Collaborated Products: 3 results
2. 村田昌之 (60380622)

# of Collaborated Projects: 3 results

# of Collaborated Products: 3 results
3. IKEZAKI Hiroaki

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
4. HIRAMINE Satoshi

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results

Ogawa Eiichi 小川 栄一

Eiichi Ogawa 小川 栄一

Research Projects

Research Products

Co-Researchers

Evaluation for the liver fibrosis and hepatocellular carcinoma incidence after HCV elimination in patients with chronic hepatitis CPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Hepatocellular carcinoma following hepatitis C virus eradication by direct-acting antivirals

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Kidney-associated molecular and immunological analysis in treatment with direct-acting antivirals for hepatitis C virus infectionPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Hepatitis C virus kinetics and optimized therapy in DAA treatmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Spontaneous clearance of Hepatitis C virus infection

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct-acting antivirals2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Long-term hepatic function of patients with compensated cirrhosis following successful direct-acting antiviral treatment for hepatitis C virus infection2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Elbasvir plus grazoprevir for patients with chronic hepatitis C genotype 1: A multicenter, real-world cohort study focusing on chronic kidney disease2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapy2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Impact of HCV kinetics on treatment outcome differs by the type of real-time HCV assay in NS3/4A protease inhibitor-based triple therapy2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological response.2014

Author(s)

Journal Title

DOI

Data Source

Ogawa Eiichi 小川栄一

Eiichi Ogawa 小川栄一